精优药业附属长春精优拟向长春市韩都鼎业房地产策划销售有限公司回购长春精优约10.06%股权

Core Viewpoint - Jingyou Pharmaceutical (00858) plans to repurchase approximately 10.06% equity in Changchun Jingyou for RMB 4.4 million, which will increase the company's ownership in Changchun Jingyou to 89.46% after the repurchase and cancellation of shares [1] Group 1 - The repurchase is seen as an appropriate opportunity for the company to strengthen its control and ownership of Changchun Jingyou without affecting normal business operations [1] - The board anticipates that the share repurchase will enhance the earnings per share of Changchun Jingyou [1]